AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Feb 4, 2015
29828_dirs_2015-02-04_0545ad67-7d17-450e-8827-e0083eca9528.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-02-02
Reporting Person: Washington Robin L (EVP, CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-02 | Common Stock | M | 11550 | $19.085 | Acquired | 61382 | Direct |
| 2015-02-02 | Common Stock | M | 4800 | $23.755 | Acquired | 66182 | Direct |
| 2015-02-02 | Common Stock | M | 11250 | $24.295 | Acquired | 77432 | Direct |
| 2015-02-02 | Common Stock | M | 5592 | $40.56 | Acquired | 83024 | Direct |
| 2015-02-02 | Common Stock | S | 24392 | $105.1379 | Disposed | 58632 | Direct |
| 2015-02-02 | Common Stock | S | 8200 | $105.9789 | Disposed | 50432 | Direct |
| 2015-02-02 | Common Stock | S | 600 | $106.8517 | Disposed | 49832 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-02 | Non-Qualified Stock Option (right to buy) | $19.085 | M | 11550 | Disposed | 2021-01-20 | Common Stock (11550) | Direct |
| 2015-02-02 | Non-Qualified Stock Option (right to buy) | $23.755 | M | 4800 | Disposed | 2020-01-28 | Common Stock (4800) | Direct |
| 2015-02-02 | Non-Qualified Stock Option (right to buy) | $24.295 | M | 11250 | Disposed | 2022-01-26 | Common Stock (11250) | Direct |
| 2015-02-02 | Non-Qualified Stock Option (right to buy) | $40.56 | M | 5592 | Disposed | 2023-02-01 | Commmon Stock (5592) | Direct |
Footnotes
F1: The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
F3: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F4: Sale prices reported for the transactions reported here range from $104.63 to $105.62. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F5: Sale prices reported for the transactions reported here range from $105.64 to $106.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F6: Sale prices reported for the transactions reported here range from $106.71 to $107.07. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.